Gene Score gda Association Type Type Original DB Sentence supporting the association PMID PMID Year
Entrez Id: 56476
Gene Symbol: ABCB10P1
ABCB10P1
0.060 Biomarker disease BEFREE The study was a cross-sectional design involving 42 children (26M/16F; mean age 10.12 ± 1.98) selected as a DCD group compared with 79 children (49M/30F; mean age 9.94 ± 2.84) identified as typical (no-DCD) for motor ability and sleep macrostructural parameters according to the MABC-2 and polysomnographic (PSG) evaluations. 31581629 2019
Entrez Id: 56476
Gene Symbol: ABCB10P1
ABCB10P1
0.060 GeneticVariation disease BEFREE MABC-2 scores can reliably predict VPT children who are not at risk of DCD. 29653831 2019
Entrez Id: 56476
Gene Symbol: ABCB10P1
ABCB10P1
0.060 Biomarker disease BEFREE High-resolution structural images were acquired from 44 children aged 7.8-12 years, including 22 children with DCD (≤16th percentile on MABC-2; no ADHD/ASD), and 22 typically developing controls (≥20th percentile on MABC-2). 28119021 2017
Entrez Id: 56476
Gene Symbol: ABCB10P1
ABCB10P1
0.060 Biomarker disease BEFREE Nineteen boys (8.25-12.75 years) participated, including 10 children with DCD (≤16th percentile on MABC-2; no ADHD/ASD), and nine typically developing controls (≥25th percentile on MABC-2). 29274848 2019
Entrez Id: 56476
Gene Symbol: ABCB10P1
ABCB10P1
0.060 Biomarker disease BEFREE When DSM-5 criteria were applied, 60 children out of 548 were classified as probable DCD (10.94%) compared to 70 children with probable DCD (12.77%) when MABC-2 was used. 31476726 2019
Entrez Id: 56476
Gene Symbol: ABCB10P1
ABCB10P1
0.060 Biomarker disease BEFREE The SCAN-3:C and SCAN-3:A test batteries were used to assess auditory processing abilities; Lucid Ability test for NVIQ; Children's Communication Checklist-2 (CCC-2) for language ability; Swanson Nolan and Pelham-IV Rating Scale (SNAP-IV) for ADHD; and the manual dexterity components of the Movement Assessment Battery for Children-2 (MABC-2) as a screening tool for DCD. 30262367 2018
Entrez Id: 117159
Gene Symbol: DCD
DCD
0.040 Biomarker disease BEFREE Further characterization of the findings was conducted in 313 Dutch IMAGE children using the Developmental Coordination Disorder Questionnaire (DCD-Q). 21473668 2012
Entrez Id: 117159
Gene Symbol: DCD
DCD
0.040 Biomarker disease BEFREE Children with impaired motor coordination (or Development Coordination Disorder - DCD) have difficulty with the predictive control of movements, evidenced by cross-sectional studies that show impaired motor imagery and action planning abilities. 28917097 2017
Entrez Id: 117159
Gene Symbol: DCD
DCD
0.040 Biomarker disease BEFREE <b>Abbreviations:</b> DCD: Developmental Coordination Disorder; sdDCD: suspected or diagnosed Developmental Coordination Disorder; RCT: randomized-controled trial. 30273508 2019
Entrez Id: 117159
Gene Symbol: DCD
DCD
0.040 Biomarker disease BEFREE Exploratory data analysis and bivariate structural equation modeling were used to estimate the familiality of MP rated by parents (Developmental Coordination Disorder Questionnaire [DCD-Q]) or teachers (Groningen Motor Observation Scale [GMO]) and to determine the familial and environmental correlation between MP and ADHD. 19218895 2009
Entrez Id: 414
Gene Symbol: ARSD
ARSD
0.020 Biomarker disease BEFREE The prevalence of left-handedness within the DCD-group is lower than that reported for ASD, and larger than in dyslexia. 30405473 2018
Entrez Id: 414
Gene Symbol: ARSD
ARSD
0.020 GeneticVariation disease BEFREE Nonparametric analyses suggest distinct trajectories and early cognitive abilities for deletion carriers who are ultimately diagnosed with intellectual disability and developmental coordination disorder as well as distinct trajectories and early social communication and cognitive abilities for duplication carriers diagnosed with ASD and intellectual disability. 28349640 2017
Entrez Id: 1789
Gene Symbol: DNMT3B
DNMT3B
0.010 GeneticVariation disease BEFREE Do video game interventions improve motor outcomes in children with developmental coordination disorder? A systematic review using the ICF framework. 30651097 2019
Entrez Id: 65260
Gene Symbol: COA7
COA7
0.010 Biomarker disease BEFREE The SCAN-3:C and SCAN-3:A test batteries were used to assess auditory processing abilities; Lucid Ability test for NVIQ; Children's Communication Checklist-2 (CCC-2) for language ability; Swanson Nolan and Pelham-IV Rating Scale (SNAP-IV) for ADHD; and the manual dexterity components of the Movement Assessment Battery for Children-2 (MABC-2) as a screening tool for DCD. 30262367 2018
Entrez Id: 6050
Gene Symbol: RNH1
RNH1
0.010 Biomarker disease BEFREE Using a multivariate regression model, ADHD combined presentation [combined versus predominantly hyperactive/impulsive and unspecified OR 4.52 (1.23-16.55), p = 0.023], age [OR 1.46 (1.14-1.88), p = 0.003], ODD/CD [OR 5.53 (2.19-14.01), p < 0.001], DCD [OR 4.22 (1.70-10.48), p = 0.002], PRI [OR 0.97 (0.94-0.99), p = 0.01] were significantly associated with recommendation of methylphenidate treatment. 28983797 2018
Entrez Id: 20
Gene Symbol: ABCA2
ABCA2
0.010 Biomarker disease BEFREE Using the guidelines of the <i>Movement Assessment Battery for Children</i> ("Movement ABC-2"), a measurement tool of motor function ability, the children were divided into a DCD group, a group identified as being at risk of DCD, and a normal control group. 31249536 2019
Entrez Id: 9372
Gene Symbol: ZFYVE9
ZFYVE9
0.010 GeneticVariation disease BEFREE Inhomogeneously discriminated EOA and DCD phenotypes (5 out of 21) revealed overlapping SARA scores with different SARA subscore profiles. 31529709 2020
Entrez Id: 7048
Gene Symbol: TGFBR2
TGFBR2
0.010 GeneticVariation disease BEFREE This study examined 23 children (group 1), aged 4-13 years, with different HCTDs (i.e., 19 with hypermobile Ehlers-Danlos syndrome (EDS)/hypermobility spectrum disorder, 3 with molecularly confirmed classical EDS, and 1 with Loeys-Dietz syndrome type 1 due to TGFBR2 mutation) and 23, age- and sex-matched children with DCD (group 2). 30070022 2018
Entrez Id: 55181
Gene Symbol: SMG8
SMG8
0.010 Biomarker disease BEFREE Using the guidelines of the <i>Movement Assessment Battery for Children</i> ("Movement ABC-2"), a measurement tool of motor function ability, the children were divided into a DCD group, a group identified as being at risk of DCD, and a normal control group. 31249536 2019
Entrez Id: 56681
Gene Symbol: SAR1A
SAR1A
0.010 GeneticVariation disease BEFREE Inhomogeneously discriminated EOA and DCD phenotypes (5 out of 21) revealed overlapping SARA scores with different SARA subscore profiles. 31529709 2020
Entrez Id: 10137
Gene Symbol: RBM12
RBM12
0.010 Biomarker disease BEFREE Included were a DSM-IV-based ADHD form, the alternative SWAN (Strengths and Weaknesses of ADHD Symptoms and Normal Behaviour scale) and the Developmental Coordination Disorder Questionnaire (DCDQ). 16442650 2006
Entrez Id: 7045
Gene Symbol: TGFBI
TGFBI
0.010 Biomarker disease BEFREE In response to limitations of the commonly adopted DTI approach, the present study employed a framework that can reconcile the 'crossing fibre' problem (i.e., constrained spherical deconvolution- CSD) to characterize white matter tissue organization of sensorimotor tracts in young adults with DCD. 30552074 2019
Entrez Id: 130497
Gene Symbol: OSR1
OSR1
0.010 Biomarker disease BEFREE Using a multivariate regression model, ADHD combined presentation [combined versus predominantly hyperactive/impulsive and unspecified OR 4.52 (1.23-16.55), p = 0.023], age [OR 1.46 (1.14-1.88), p = 0.003], ODD/CD [OR 5.53 (2.19-14.01), p < 0.001], DCD [OR 4.22 (1.70-10.48), p = 0.002], PRI [OR 0.97 (0.94-0.99), p = 0.01] were significantly associated with recommendation of methylphenidate treatment. 28983797 2018
Entrez Id: 51380
Gene Symbol: CSAD
CSAD
0.010 Biomarker disease BEFREE In response to limitations of the commonly adopted DTI approach, the present study employed a framework that can reconcile the 'crossing fibre' problem (i.e., constrained spherical deconvolution- CSD) to characterize white matter tissue organization of sensorimotor tracts in young adults with DCD. 30552074 2019
Entrez Id: 54982
Gene Symbol: CLN6
CLN6
0.300 Biomarker disease CTD_human Altered biometal homeostasis is associated with CLN6 mRNA loss in mouse neuronal ceroid lipofuscinosis. 23789114 2013